Home › Funds › RTW INVESTMENTS, LP › CADL

RTW INVESTMENTS, LP position in CADL

CANDEL THERAPEUTICS INC · Health Care

RTW INVESTMENTS, LP reported holding 6,422,018 shares of CADL (CANDEL THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$66.1M, representing 0.56% of its reported portfolio and ranking #41 among its reported holdings. RTW INVESTMENTS, LP has disclosed CADL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)6.42M sh
Reported value held$66.15M
Portfolio Weight0.56%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's CADL position evolved

RTW INVESTMENTS, LP first disclosed a stake in CADL in Q1 2026 at 6,422,018 shares (US$31.5M). The position peaked in Q2 2026 at 6,422,018 shares, worth US$66.1M. Across 2 filings, RTW INVESTMENTS, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 6,422,018 shares valued at US$66.1M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 6.42M $31.47M New
Q2 2026 6.42M $66.15M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CADL and 13F data

CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 83 other funds we track also report a position in CADL — the largest reported positions include ACORN CAPITAL ADVISORS, LLC (US$36.0M), Portolan Capital Management, LLC (US$36.0M), Saturn V Capital Management LP (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CADL

All CADL fund holders →

FAQ

How long has RTW INVESTMENTS, LP held CADL?

RTW INVESTMENTS, LP has disclosed CADL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is RTW INVESTMENTS, LP's current position in CADL?

As of Q2 2026, RTW INVESTMENTS, LP holds 6.42M shares of CADL (CANDEL THERAPEUTICS INC), valued at $66.15M, representing 0.56% of its reported portfolio and ranking #41.

Has RTW INVESTMENTS, LP been buying or selling CADL?

In the latest 13F filing (Q2 2026), RTW INVESTMENTS, LP held unchanged its position in CADL. The position peaked in Q2 2026 at 6.42M shares.

Which other funds hold CADL?

Other major institutional holders of CADL include ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, Saturn V Capital Management LP, among 83 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.